PMID: 8593604Oct 1, 1995Paper

A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity

Gene Therapy
D Moritz, B Groner

Abstract

The elimination of tumor cells by cytotoxic T lymphocytes (CTLs) could become the basis of a biological cancer therapy. The recognition specificity of cytotoxic T lymphocytes (CTLs) can be genetically modified by stable introduction of chimeric T cell receptor genes and thus be directed towards tumor cells. We designed a recombinant T cell receptor (TCR) component consisting of a single chain Fv derivative of a monoclonal antibody (scFv) serving as the extracellular antigen-binding domain and the zeta-chain of the TCR/CD3 complex serving as a signal transducing domain. Three chimeric receptor constructs differing in their molecular structure were derived and their functions in transduced T cells compared. A construct in which the scFv domain, specific for the ErbB-2 receptor, was fused directly to the zeta-chain, and two constructs containing different hinge regions between the functional domains, were made. The hinge regions serve as spacers which increase the distance of the scFv moiety from the plasma membrane. Only the two scFv-zeta chimeras containing a hinge region showed ErbB-2 binding activity, when expressed in T cells. The scFv-zeta construct which lacks a spacer segment did not. Consistently, only the spacer-containi...Continue Reading

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.